Progressive external ophthalmoplegia, autosomal dominant, type 1 (Q97268): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank

Revision as of 13:21, 16 August 2026

Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-1 (PEOA1) is caused by mutation in the nuclear-encoded DNA polymerase-gamma gene (POLG; 174763) on chromosome 15q25. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Progressive external ophthalmoplegia caused by mutation in the POLG gene is associated with more complicated phenotypes than those forms caused by mutation in the ANT1 or C10ORF2 genes.
Language Label Description Also known as
default for all languages
ID_1743854054
    English
    Progressive external ophthalmoplegia, autosomal dominant, type 1
    Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-1 (PEOA1) is caused by mutation in the nuclear-encoded DNA polymerase-gamma gene (POLG; 174763) on chromosome 15q25. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Progressive external ophthalmoplegia caused by mutation in the POLG gene is associated with more complicated phenotypes than those forms caused by mutation in the ANT1 or C10ORF2 genes.

      Statements

      CID11:ID_1743854054
      0 references
      dki-india-ID_1743854054
      0 references
      Concluído
      0 references